Editorial: The Fruits of the Genomic Revolution.
作者信息
Rebbeck Timothy R, Sellers Thomas A
机构信息
Dana Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, Massachusetts.
Moffit Cancer Center, Tampa, Florida.
出版信息
Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):362. doi: 10.1158/1055-9965.EPI-16-0914.
Abstract
摘要
相似文献
1
Editorial: The Fruits of the Genomic Revolution.社论：基因组革命的成果
Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):362. doi: 10.1158/1055-9965.EPI-16-0914.
2
Radiogenomics: radiobiology enters the era of big data and team science.放射基因组学：放射生物学进入大数据和团队科学时代。
Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):709-13. doi: 10.1016/j.ijrobp.2014.03.009.
3
The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations.NGS 技术在癌症基因组组织描绘中的威力：从突变到结构变异和表观遗传改变。
Cancer Metastasis Rev. 2011 Jun;30(2):199-210. doi: 10.1007/s10555-011-9278-z.
4
Genomics of Alzheimer's disease: Value of high-throughput genomic technologies to dissect its etiology.阿尔茨海默病的基因组学：高通量基因组技术在剖析其病因方面的价值。
Mol Cell Probes. 2016 Dec;30(6):397-403. doi: 10.1016/j.mcp.2016.09.001. Epub 2016 Sep 13.
5
Genomic Insight into the Role of lncRNA in Cancer Susceptibility.长链非编码RNA在癌症易感性中作用的基因组学洞察
Int J Mol Sci. 2017 Jun 9;18(6):1239. doi: 10.3390/ijms18061239.
6
Low-penetrance susceptibility to hematological malignancy.低外显率血液系统恶性肿瘤易感性。
Curr Opin Genet Dev. 2010 Jun;20(3):245-50. doi: 10.1016/j.gde.2010.03.004. Epub 2010 Apr 8.
7
Leveraging cancer genome information in hematologic malignancies.利用癌症基因组信息治疗血液系统恶性肿瘤。
J Clin Oncol. 2013 May 20;31(15):1885-92. doi: 10.1200/JCO.2013.48.7447. Epub 2013 Apr 15.
8
Clinical Implications of Cancer Genomics: A Call for Papers.癌症基因组学的临床意义：征文启事。
PLoS Med. 2016 Apr 26;13(4):e1002016. doi: 10.1371/journal.pmed.1002016. eCollection 2016 Apr.
9
Next generation sequencing technologies in cancer diagnostics and therapeutics: A mini review.癌症诊断与治疗中的下一代测序技术：一篇综述
Cell Mol Biol (Noisy-le-grand). 2015 Oct 30;61(5):91-102.
10
The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance.后基因组时代乳腺癌风险的遗传学：关于研究设计的思考，以超越BRCA并迈向临床相关性。
Breast Cancer Res. 2016 Oct 3;18(1):99. doi: 10.1186/s13058-016-0759-4.
引用本文的文献
1
Precancer Atlas to Drive Precision Prevention Trials.癌前图谱推动精准预防试验。
Cancer Res. 2017 Apr 1;77(7):1510-1541. doi: 10.1158/0008-5472.CAN-16-2346.
本文引用的文献
1
The new genomics: global views of biology.新基因组学：生物学的全球视野。
Science. 1996 Oct 25;274(5287):536-9. doi: 10.1126/science.274.5287.536.
Zotero 插件